Acute starvation, particularly in children, is often encountered due to infections. This is frequently accompanied by fever and requires antipyretic therapy. Since acetaminophen is widely used under these circumstances, we determined its toxicity (LD O) in young (8 day old) and adult male mice (strain CD-1). ~nimai)s were deprived of food for 6 hours with free access to water. Mice of both ages were intubated orally with either a drug suspension (500 to 4000 mg/kg) in tragacanth (0.25%) or vehicle and twenty-four hour LD50 data were computed. In adults, food deprivation for 6 hrs decreased LDsO from 1500 mg (control) to 750 mg (starved). In yound pups, however, starvation did not , change LD50 of acetaminophen. Furthermore, when we compared the half-life of acetaminophen (500 mglkg, P.O., single dose) in the young adult control mice, the data show that the mean halflife was longer in the young (4.59 hrs) than in the adults (0.85 hrs). The fraction of the drug absorbed was also higher in the young (78%) compared to the adults (57%). Thus,,these results indicate that acute starvation in young mice does not alter the toxicity of acetaminophen which is In contrast to adults. The reasons for this phenomenon are unknown. Phenytoin, an anticonvulsant which is commonly used in the treatment of epilepsy, is teratogenic in humans and produces cleft palate in susceptible rodents. We therefore investigated the effects of a teratogenic dose (50 mg/kg,S.C.) of phenytoin in the susceptible Ajax (A/J) and the resistant C57BL6 (B6) inbred strains of mice during the critical period of palatal differentiation (11-14 days). The drug produced 50% clefts in the A/J strain compared to 1.6% clefts in the B6 strain of mice. We further investigated whether phenytoin affects fetal palatal RNA and protein synthesis as do other clefting teratogens, glucocorticoids. Thus, a single dose of phenytoin (50 mg/kg) or vehicle was administered (S.C.) on the 12th day of pregnancy to both strains and RNA and protein synthesis was measured in fetal palates at various time intervals (3-72 hrs) by incorporation of 3H-uridine (RNA) and 1 4~ leucine (protein). The results indicate that phenytoin produces a marked and persistent inhibition of RNA and protein synthesis in the fetal palates of the susceptible A/J strain. However, in the resistent strain, this drug produces only a slight and transient inhibition of palatal RNA synthesis, but does not affect protein synthesis. Thus, inhibition of palatal RNA and protein synthesis by phenytoin may be related to its teratogenic action on palatal differentiation at the critical period of development.
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Phenytoin, an anticonvulsant which is commonly used in the treatment of epilepsy, is teratogenic in humans and produces cleft palate in susceptible rodents. We therefore investigated the effects of a teratogenic dose (50 mg/kg,S.C.) of phenytoin in the susceptible Ajax (A/J) and the resistant C57BL6 (B6) inbred strains of mice during the critical period of palatal differentiation (11-14 days). The drug produced 50% clefts in the A/J strain compared to 1.6% clefts in the B6 strain of mice. We further investigated whether phenytoin affects fetal palatal RNA and protein synthesis as do other clefting teratogens, glucocorticoids. Thus, a single dose of phenytoin (50 mg/kg) or vehicle was administered (S.C.) on the 12th day of pregnancy to both strains and RNA and protein synthesis was measured in fetal palates at various time intervals (3-72 hrs) by incorporation of 3H-uridine (RNA) and 1 4~ leucine (protein). The results indicate that phenytoin produces a marked and persistent inhibition of RNA and protein synthesis in the fetal palates of the susceptible A/J strain. However, in the resistent strain, this drug produces only a slight and transient inhibition of palatal RNA synthesis, but does not affect protein synthesis. Thus, inhibition of palatal RNA and protein synthesis by phenytoin may be related to its teratogenic action on palatal differentiation at the critical period of development.
CONTENT AND ORGANIZATION OF SP ERMATOZOAN DNA. g-ss-e~ F. Soyka, Donald R. Mattison, Robert J. Kramer and
The development of laser-based instrumentation has made possible the determination of individual cell DNA content at rates of 20,00O/min and above. Forward light scatter, an index of cell shape and refractive index, can be concurrently measured. Moreover, subpopulations of cells can be sorted based on either of these parameters and collected for additional biochemical or morphological analysis. In order to determine changes occuring during epididymal maturation individual caput and cauda epididyma were obtained from C57BL/6N and AKR mice. Sperm were rinsed free in saline-EDTA, washed, fixed in ethanol and stained with propidiam iodide. A Coulter TPS-1 cell sorter was employed. In some studies freeze-thawing and sonication were employed to obtain a high yield of isolated sperm heads. A discrete homogeneous peak of fluorescent intensity corresponding to the haploid chromosome DNA content was defined and the purity confirmed by collection and examination by flourescent microscopy.
Caput sperm heads had lesser Elourescence than those Erom the cauda. Heating at 100 C for 10 min resulted in a shift toward greater flourescence. These changes indicate altered organization of DNA. Conclusions: The flourescent activated cell sorter can be used to measure DNA content and morphology of individual sperm with a precision and speed not previously possible. A small percent of patients treated with phenytoin (DPH) develop hepatotoxicity. Covalent binding of arene oxide'metabolites (AOM) of the drug to cell macromolecules could result in cell death and secondary "hypersensitivity" reactions (fever, rash, eosinophilia). We tested the hypothesis that DPH hepatotoxicity results from decreased ability to detoxify AOM by exposing lymphocytes to AOM generated by a murine hepatic microsoma1 system. Cells from 17 controls (including 3 patients chronically treated with DPH without side effects) exhibited no toxicity (by trypan blue dye exclusion) over a DPH concentration range of 31-125 pM. When an inhibitor of epoxide hydrolase (TCPO) was added to the incubation, a dose-dependent increase in cell death was noted. AOM of DPH are thus cytotoxic in the system. Cells from 3 patients who experienced DPH hepatotoxicity manifested damage in the absence of TCPO. Cells from both parents of one patient, and the mother of a second showed an intermediate response. A sibling's cells had the same dose-response curve as one of the patients. All patients' cells showed enhanced toxicity from mephenytoin, but a.norma1 response to acetaminophen (metabolites of the latter are not AOM). DPH hepatotoxicity may be based on decreased ability to detoxify AOM, and this appears to be a heritable trait.
SUSTAINED RELEASE THEOPHYLLINE (SRT): A SIGNIFICANT
375 ADVANCE IN THE TREATMENT OF CHILDHOOD ASTHMA. , E. Tabachnik, P. Scott, S. MacLeod, J. Correia, C. Newth, and H. Levison, Hosp. for Sick Children, TorontoR
The efficacy and safety of an SRT preparation (Theo-Bur ) was compared to regular release theophylline (RRT) (~heolair") in the treatment of childhood asthma. We studied 34 children aged 6 -12 years (mean 9.3 years) for 8 weeks. Both the SRT and RRT preparations were administered for 4 weeks in a randomized crossover design. Individualized theophylline dosage was determined after pre-study measurement of a time concentration curve at steady state on SRT. Mean (+SD) dosage for SRT and RRT was 22.6 + 5.3 and 21.9 + 5.3 mg7kg/24 hours respectively. The SRT was aaministered 12 hourly; the RRT 6 hourly. Expiratory flow rate and lung volumes were assessed every 2 weeks. Peak flow rates were measured at home twice daily. A diary of symptomatology including wheezing, cough, appetite, activity and side effects was kept. No difference in pulmonary function or side effects was observed between the 2 treatments. However, breakthrough wheezing was significantly more frequent (p < .01) during RRT therapy. Pill counts and serum theophylline concentration monitoring showed better compliance with SRT treatment (p < .01). Subjectively, SRT therapy was preferred by 33 of 34 families. These results demonstrate conclusively that even in young children with rapid theophylline clearance, an SRT preparation administered twice daily is effective and safe. Because of decreased wheezing, improved compliance, and greater patient acceptance, SRT has definite clinical advantage over RRT in pediatrics. 12 53f12 10+4 25f12 Ilk7 13 72k7 25k7 2f0.6 .9f1.2 38-42 wks. 9 43f12 10f5 34f15 12f9 7 70f8 26k8 3k1.5 .7f0.7 *mean f S.D. Throughout the study, the plasma T levels achieved were 9.0i0.6 ug/ml. The major metabolites were T, C, DMU, & MU in plasma and urine. Urinary % of DMU increased with post-conceptional (PC)age and accounted for the decrease in % of T (r=-0.82, p<0.001). The fraction of C in plasma and urine remained constant.MX & TB were detectable in minute amounts. TB appeared only at later PC ages. Conclusion: 1) N-oxidation and C3-demethylation were active and progressively increased with post-conceptional age, and 2) The differential activities of N-oxidation/C3-demethylation with C1-demethylation implies multiple cytochrome P450 enzyme systems for theophylline metabolism.
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